Target intelligence / Profile preview

Hormonally up-regulated Neu-associated kinase (HUNK)

Target
HUNK
Molecular classification
Enzyme, Serine/threonine protein kinase, SNF1/AMPK family-related protein kinase
01

Overview

Hormonally up-regulated Neu-associated kinase (HUNK) is a serine/threonine protein kinase originally identified in the murine mammary gland. It has notable homology to the SNF1/AMPK family and features unique structural domains, including a catalytic kinase domain, a SNF1 homology domain (SNH), ubiquitin-associated domain (UBA), and a distinct C-terminal domain. HUNK is highly expressed in HER2-positive breast cancer cell lines, where it promotes tumor progression and mediates resistance to HER2/ErbB2 inhibitors, likely by regulating autophagy and cell survival pathways. Although HUNK’s precise substrates and full physiological functions remain elusive, targeting HUNK is beginning to show preclinical promise for impairing breast tumor growth and overcoming drug resistance[1]. HUNK is encoded at 21q22.11 and is molecularly synonymous with MAK-V, with research focusing on its potential as a novel therapeutic target in oncology, especially breast cancer.

Other names
HUNKMAK-VB19Serine/threonine-protein kinase MAK-VHormonally up-regulated neu tumor-associated kinaseMetastasis associated protein kinase in VMR tumor family
02

Mechanism of action

Potential therapeutic mechanisms target HUNK’s kinase activity to block tumor growth and overcome drug resistance by inhibiting autophagy in HER2-positive breast cancer

03

Biological functions

Signal transductionCell proliferationApoptosisMigrationEndocytosisAutophagy
04

Disease associations

Cancer (particularly HER2-positive breast cancer)Potential (unconfirmed) roles in nervous system malignancies
05

Safety considerations

Since HUNK has not been fully characterized and lacks known physiological substrates, off-target effects and unanticipated physiological impacts represent therapeutic challenges
06

Interacting drugs

None known (HUNK is an emerging target; no direct approved drugs yet)
07

Biomarkers

Increased HUNK expression may mark HER2-positive/ErbB2-positive breast cancer and drug-resistant HER2-positive tumors

Beyond the preview

Go deeper on Hormonally up-regulated Neu-associated kinase (HUNK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hormonally up-regulated Neu-associated kinase (HUNK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call